Analysis of Risk Factors for Ovarian Metastasis in 138 Cases of Cervical Adenocarcinoma
-
摘要:
目的 探讨宫颈腺癌卵巢转移的危险因素。 方法 回顾性分析1993年1月至2008年12月江西省妇幼保健院肿瘤科收治的138例宫颈腺癌患者的临床病理资料(首次治疗方式均为手术治疗), 采用SPSS 19.0统计软件Fisher精确检验分析和Logistic回归分析其卵巢转移的危险因素。 结果 138例宫颈腺癌Ⅰ~Ⅱ期患者中发生卵巢转移4例, 转移率2.90%;Fisher精确检验分析显示: 临床分期(P < 0.01)、宫旁受侵(P < 0.01)、输卵管转移(P < 0.05)、盆腔淋巴结转移(P < 0.01)与卵巢转移相关; Logistic回归分析显示: FIGO 2009临床分期(0R=27.923)、输卵管转移(0R=133.000)与卵巢转移相关。 结论 对于临床Ⅰ~Ⅱ期宫颈腺癌患者保留卵巢存在一定风险, 但是对于希望保留卵巢功能的年轻患者, 在仔细评估卵巢转移高危因素后可考虑保留卵巢。 Abstract:Objective To analyze risk factors for ovarian metastasis from cervical adenocarcinoma. Methods The clinicopathologic data of 138 patients with adenocervical cancer admitted to the Department of Gynecological Oncology, Jiangxi Maternity and Child Healthcare Hospital between January 1993 and December 2000 were analyzed retrospectively.The risk factors of ovarian metastasis were subjected to Fisher accurate inspection analysis and logistic regression analysis using SPSS 19.0. Results Among the 138 cervical adenocarcinoma(stagesⅠandⅡ) patients, 4 had ovarian metastasis and the transfer rate was 2.90%.The Fisher accurate inspection analysis showed that ovarian metastasis was related to the clinical stage(P < 0.01), palace metastasis(P < 0.01), fallopian tube metastasis(P < 0.05), and pelvic lymph node metastasis(P < 0.01).The logistic regression analysis showed that ovarian metastasis was related to the FIGO clinical stage(OR = 27.923) and oviduct metastasis(OR = 133.000). Conclusion There are some risks for clinical stageⅠ-Ⅱcervical adenocarcinoma patients.The risk factors for ovarian metastasis for young patients who want to keep ovaries must be carefully assessed. -
Key words:
- Cervical adenocarcinoma /
- Ovarian metastasis /
- Risk factors
-
表 1 宫颈腺癌卵巢转移危险因素Fisher精确检验分析
Table 1. Fisher accurate inspection analysis of risk factors for ovarian metastasis from cervical adenocarcinoma
表 2 宫颈腺癌卵巢转移危险因素Logistic回归分析
Table 2. Logistic regression analysis of risk factors for ovarian metastasis from cervical adenocarcinoma
-
[1] Kokawa K, Takekida S, Kamiura S, et al. The incidence, treatment and prognosis of cervical carcinoma in young women: a retrospective analysis of 4, 975 cases in Japan[J]. Eur J Gynaecol Oncol, 2010, 31(1): 37-43. [2] Hovland S, Muller S, Skomedal H, et al. E6/E7 mRNA expression analysis: a test for the objective assessment of cervical adenocarcinoma in clinical prognostic procedure[J]. Int J Oncol, 2010, 36(6): 1533-1539. http://www.spandidos-publications.com/ijo/36/6/1533/download [3] Howlett RI, Marrentt LD, Innes MK, et al. Decreasing incidence of cervical adenocarcinoma in Ontario: Is this related to improved endocervical Pap test sampling[J]? Int J Cancer, 2006, 120: 362-367. [4] Vesco KK, Whidock EP, Eder M, et al. Risk Factors and Other Epidemiologic Considerations for Cervical Cancer Screening: A Narrative Review for the U. S. Preventive Services Task Force[J]. Ann Internal Med, 2011, 155(10): 698-705. doi: 10.7326/0003-4819-155-10-201111150-00377 [5] Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010[J]. Ca Cancer J Clin, 2010, 60(5): 277-300. doi: 10.3322/caac.20073 [6] Kokawa K, Takekida S, Kamiura S, et al. The incidence, treatment and prognosis of cervical carcinoma in young women: a retrospective analysis of 4, 975 cases in Japan[J]. European journal of gynaecoligical oncology, 2010, 31(1): 37-43. [7] Hovland S, Muller S, Skomedal H, et al. E6/E7 mRNA expression analysis: A test for the objective assessment of cervical adenocarcinoma in clinical prognostic procedure[J], Internation Journal of Oncology, 2010, 36(6): 1533-1539. [8] Shimada M, Kigawa J, Nishimura R, et al. Ovarian metastases in carcinoma of the uterine cervix[J]. Gynecologic Oncology, 2006, 101(2): 234-237. [9] Lilian TG, Beauchemin MC, Thomas G. Adenocarcinoma: A unique cervical cancer[J]. Gynecologic Oncology, 2010, 116(1): 140-146. doi: 10.1016/j.ygyno.2009.09.040 [10] Vijaya G, Thomas J, Herzog, et al. Prognostic significance of adenocarcinoma histology in women with cervical cancer[J]. Gynecologic Oncology, 2012, 125(2): 287-291. doi: 10.1016/j.ygyno.2012.01.012 -
点击查看大图
表(2)
计量
- 文章访问数: 6
- HTML全文浏览量: 45
- PDF下载量: 1
- 被引次数: 0
下载:
